Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results

Rhea-AI Summary

Boston Scientific (NYSE: BSX) will participate in Bernstein's 42nd Annual Strategic Decisions Conference on May 27, 2026, with CEO Mike Mahoney and Dr. Janar Sathananthan in a 50-minute Q&A at ~8:00 a.m. ET. The company will webcast its Q2 2026 earnings call on July 29, 2026 at 8:00 a.m. ET, hosted by Mike Mahoney and CFO Jon Monson. A news release with Q2 results will be issued prior to the call, and live webcasts plus replays will be available at the company's investor site approximately one hour after each event.

News Market Reaction – BSX

+0.62%

+0.62% Session close to close

In the May 4 session, BSX gained 0.62%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement details Boston Scientific’s upcoming participation at Bernstein’s conference and t...

Analysis

This announcement details Boston Scientific’s upcoming participation at Bernstein’s conference and the timing of its Q2 2026 earnings call on July 29, 2026. It mirrors prior "conferences,earnings" notices that simply set expectations for when management will discuss results. In context of recent strong Q1 2026 filings and active M&A, investors may focus on how Q2 performance, updated guidance, and integration progress are addressed when the full financial release becomes available.

Key Figures

Bernstein Q&A duration: 50 minutes Bernstein session time: 8:00 a.m. ET Q2 2026 call time: 8:00 a.m. ET +1 more

4 metrics

Bernstein Q&A duration 50 minutes Question-and-answer session length at Bernstein’s 42nd Annual Strategic Decisions Conference

Bernstein session time 8:00 a.m. ET Start time for conference Q&A on May 27, 2026

Q2 2026 call time 8:00 a.m. ET Start time for Q2 2026 results conference call on July 29, 2026

Quarter end date June 30, 2026 End date for the second quarter 2026 being discussed on the call

Previous Conferences,earnings Reports

5 past events · Latest: Mar 30 (Neutral)

Same Type Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Mar 30	Earnings call scheduling	Neutral	-9.0%	Announced webcast to discuss Q1 2026 financial results and highlights.
Jan 02	Conference and call plan	Neutral	-0.7%	Outlined J.P. Morgan conference participation and Q4/FY 2025 earnings call date.
Sep 02	Investor Day and call	Neutral	+1.1%	Scheduled 2025 Investor Day and Q3 2025 earnings conference call webcasts.
Jul 01	Q2 call scheduling	Neutral	-2.5%	Set timing for Q2 2025 results call with webcast and replay details.
Apr 01	Q1 call scheduling	Neutral	+0.4%	Announced Q1 2025 results call and webcast access information.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Similar conferences/earnings scheduling announcements have typically seen modest share moves around the news, with a slight negative skew on average.

Recent Company History

Recent history shows Boston Scientific regularly pre-announces conferences and earnings calls, such as Q1 2026 and prior quarterly result discussions on Apr 22, 2026, Jul 23, 2025, and Apr 23, 2025. These events outline upcoming result dates and management participation, without providing new financials at the time of the notice. Average share move around past "conferences,earnings" announcements was about -2.14%. Today’s article similarly sets expectations for a Bernstein appearance and the Q2 2026 call timing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MARLBOROUGH, Mass., May 4, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 42^nd Annual Strategic Decisions Conference on Wednesday, May 27, 2026. Mike Mahoney, chairman and chief executive officer, and Janar Sathananthan, M.D., chief medical officer, Interventional Cardiology Therapies, will participate in a 50-minute question-and-answer session with the host analyst at approximately 8:00 a.m. ET.

Additionally, the company will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2026, on Wednesday, July 29, 2026, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney and Jon Monson, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the second quarter 2026 on July 29 prior to the conference call.

A live webcast and replay for each event will be accessible at https://investors.bostonscientific.com. The replays will be available approximately one hour following the completion of each event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and follow us on LinkedIn.  

CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com

Lauren Tengler
Investor Relations
+1 (508) 683-4479
BSXInvestorRelations@bsci.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-participation-in-bernsteins-42nd-annual-strategic-decisions-conference-and-conference-call-discussing-second-quarter-2026-results-302760793.html

SOURCE Boston Scientific Corporation

FAQ

When will Boston Scientific (BSX) present at Bernstein's 42nd Annual Strategic Decisions Conference?

Boston Scientific will present on May 27, 2026 at approximately 8:00 a.m. ET. According to the company, CEO Mike Mahoney and Dr. Janar Sathananthan will take part in a 50-minute question-and-answer session with the host analyst.

What time and date is Boston Scientific's (BSX) Q2 2026 earnings conference call?

The Q2 2026 earnings conference call is scheduled for July 29, 2026 at 8:00 a.m. ET. According to the company, management will issue a news release with results prior to the call and host a live webcast and replay.

Who will host Boston Scientific's (BSX) July 29, 2026 earnings call?

The call will be hosted by CEO Mike Mahoney and CFO Jon Monson. According to the company, they will discuss financial results and business highlights for the quarter ended June 30, 2026, during the webcast.

Where can investors access the Boston Scientific (BSX) conference and earnings webcasts and replays?

Investors can access live webcasts and replays at https://investors.bostonscientific.com. According to the company, replays will be available approximately one hour after each event concludes.

Will Boston Scientific (BSX) release Q2 2026 financial results before the July 29 call?

Yes, the company will issue a news release with Q2 2026 results prior to the July 29, 2026 conference call. According to the company, that release will precede the live webcast and discussion.